Jithma P. Abeykoon

2.5k total citations
94 papers, 913 citations indexed

About

Jithma P. Abeykoon is a scholar working on Pathology and Forensic Medicine, Physiology and Genetics. According to data from OpenAlex, Jithma P. Abeykoon has authored 94 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 36 papers in Physiology and 30 papers in Genetics. Recurrent topics in Jithma P. Abeykoon's work include Histiocytic Disorders and Treatments (30 papers), Chronic Lymphocytic Leukemia Research (28 papers) and Lymphoma Diagnosis and Treatment (27 papers). Jithma P. Abeykoon is often cited by papers focused on Histiocytic Disorders and Treatments (30 papers), Chronic Lymphocytic Leukemia Research (28 papers) and Lymphoma Diagnosis and Treatment (27 papers). Jithma P. Abeykoon collaborates with scholars based in United States, China and Greece. Jithma P. Abeykoon's co-authors include Prashant Kapoor, Saurabh Zanwar, Ruben A. Mars, Daniel Schupack, Purna Kashyap, Kavita Narang, Sonja Šuvakov, Madugodaralalage D. S. K. Gunaratne, Jane Vermunt and Ranine Ghamrawi and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jithma P. Abeykoon

79 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jithma P. Abeykoon United States 14 328 208 164 150 147 94 913
Shuang Liu China 20 306 0.9× 124 0.6× 196 1.2× 96 0.6× 48 0.3× 90 1.3k
D. Alpizar-Rodriguez Switzerland 17 460 1.4× 110 0.5× 149 0.9× 93 0.6× 142 1.0× 37 1.5k
Yoko Obata Japan 18 242 0.7× 81 0.4× 81 0.5× 89 0.6× 57 0.4× 78 996
Thomas El Jammal France 11 190 0.6× 131 0.6× 400 2.4× 302 2.0× 77 0.5× 27 1.1k
Katherine Ma O’Reilly Ireland 13 193 0.6× 105 0.5× 116 0.7× 140 0.9× 31 0.2× 33 1.1k
Roman Crazzolara Austria 17 385 1.2× 285 1.4× 36 0.2× 31 0.2× 217 1.5× 58 1.1k
Ashok Kumar Yadav India 19 156 0.5× 66 0.3× 62 0.4× 67 0.4× 52 0.4× 103 1.1k
Alyssa Parian United States 22 201 0.6× 265 1.3× 89 0.5× 73 0.5× 50 0.3× 75 1.3k
Katharina Lechner Germany 19 295 0.9× 98 0.5× 23 0.1× 247 1.6× 114 0.8× 73 1.2k
Natasha Kekre Canada 20 285 0.9× 649 3.1× 32 0.2× 81 0.5× 513 3.5× 82 1.6k

Countries citing papers authored by Jithma P. Abeykoon

Since Specialization
Citations

This map shows the geographic impact of Jithma P. Abeykoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jithma P. Abeykoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jithma P. Abeykoon more than expected).

Fields of papers citing papers by Jithma P. Abeykoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jithma P. Abeykoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jithma P. Abeykoon. The network helps show where Jithma P. Abeykoon may publish in the future.

Co-authorship network of co-authors of Jithma P. Abeykoon

This figure shows the co-authorship network connecting the top 25 collaborators of Jithma P. Abeykoon. A scholar is included among the top collaborators of Jithma P. Abeykoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jithma P. Abeykoon. Jithma P. Abeykoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Durot, Éric, Jithma P. Abeykoon, Damien Roos‐Weil, et al.. (2025). Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia. Seminars in Hematology. 62(2). 120–125. 1 indexed citations
3.
Hershkovitz‐Rokah, Oshrat, Jithma P. Abeykoon, Aishwarya Ravindran, & Gaurav Goyal. (2025). Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration. Haematologica. 110(11). 2603–2619.
4.
Kapoor, Prashant, Meletios Α. Dimopoulos, Stephen M. Ansell, et al.. (2025). Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease. Seminars in Hematology. 62(2). 90–105. 1 indexed citations
5.
Abeykoon, Jithma P., Saurabh Zanwar, Gordon Ruan, et al.. (2025). Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants. Leukemia. 39(4). 991–994. 3 indexed citations
6.
Abeykoon, Jithma P., Shuhei Asada, Gui‐Qi Zhu, et al.. (2025). Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma. Journal of Clinical Investigation. 135(17). 1 indexed citations
7.
8.
Ruan, Gordon, Saurabh Zanwar, Aishwarya Ravindran, et al.. (2024). Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis. American Journal of Hematology. 99(5). 871–879. 9 indexed citations
9.
Banks, Samantha A., Jithma P. Abeykoon, Karen L. Rech, et al.. (2024). SLC29A3 Pathogenic Variants Resulting in Dural Based Fibroinflammatory Mass Lesions and H Syndrome Treated With Cobimetinib. Neurology Genetics. 10(6). e200197–e200197.
10.
Nathoo, Nabeela, Daniel P. Larson, Yong Guo, et al.. (2024). Central nervous system crystal‐storing histiocytosis: A case report and literature review. European Journal of Neurology. 32(1). e16528–e16528. 1 indexed citations
11.
Makras, Polyzois, Dana Erickson, Caroline Davidge‐Pitts, et al.. (2024). Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder. The Journal of Clinical Endocrinology & Metabolism. 110(6). 1756–1766. 3 indexed citations
12.
Bennani, N. Nora, Gaurav Goyal, Aishwarya Ravindran, et al.. (2024). Efficacy of Small Molecule Kinase Inhibitors in Histiocytic Neoplasms with Non-BRAFV600E Mutations: Concordance of Pre-Clinical Predictions to Clinical Responses. Blood. 144(Supplement 1). 4564–4564. 1 indexed citations
13.
Abeykoon, Jithma P., et al.. (2023). BRAF testing modalities in histiocytic disorders: Comparative analysis and proposed testing algorithm. American Journal of Clinical Pathology. 160(5). 483–489. 2 indexed citations
14.
Ravindran, Aishwarya, Surendra Dasari, Gordon Ruan, et al.. (2023). Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells. Modern Pathology. 36(10). 100268–100268. 15 indexed citations
15.
Goyal, Gaurav, Joshua Richman, Jithma P. Abeykoon, et al.. (2023). Spectrum of second primary malignancies and cause-specific mortality in pediatric and adult langerhans cell histiocytosis. Leukemia Research. 126. 107032–107032. 7 indexed citations
16.
Goyal, Gaurav, Jithma P. Abeykoon, Chen Dai, et al.. (2023). Long-term outcomes among adults with Langerhans cell histiocytosis. Blood Advances. 7(21). 6568–6578. 10 indexed citations
17.
Abeykoon, Jithma P., Iuliana Vaxman, Sanjay V. Patel, et al.. (2022). Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma. British Journal of Haematology. 199(1). 95–99. 17 indexed citations
18.
Banks, Samantha A., M. Tariq Bhatti, Ronald S. Go, et al.. (2022). Ophthalmologic Involvement in Adults with Histiocytic Disorders. Ophthalmology. 130(1). 77–86. 2 indexed citations
19.
Hazim, Antonious, Gordon Ruan, Marie Hu, et al.. (2021). Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. American Journal of Hematology. 96(12). 1604–1610. 10 indexed citations
20.
Abeykoon, Jithma P., Wilson I. Gonsalves, Jennifer L. Oliveira, & Prashant Kapoor. (2017). POEMS syndrome: An elusive diagnosis. American Journal of Hematology. 92(11). 1269–1270.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuang Liu Breakdown of academic impact, for papers by D. Alpizar-Rodriguez Breakdown of academic impact, for papers by Yoko Obata Breakdown of academic impact, for papers by Thomas El Jammal Breakdown of academic impact, for papers by Katherine Ma O’Reilly Breakdown of academic impact, for papers by Roman Crazzolara Breakdown of academic impact, for papers by Ashok Kumar Yadav Breakdown of academic impact, for papers by Alyssa Parian Breakdown of academic impact, for papers by Katharina Lechner Breakdown of academic impact, for papers by Natasha Kekre
Rankless by CCL
2026